Synovics Pharmaceuticals, Inc. (SYVC)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jan 30, 2026

Synovics Pharmaceuticals Company Description

Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States.

The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma relief, and laxatives.

It packages and distributes its products to chain drug stores, wholesalers, and distributors in the United States.

The company was formerly known as Bionutrics Inc. and changed its name to Synovics Pharmaceuticals, Inc. in 2006.

Synovics Pharmaceuticals, Inc. was founded in 1983 and is based in Fort Lauderdale, Florida. Synovics Pharmaceuticals, Inc. operates as a subsidiary of Maneesh Pharmaceuticals Limited.

Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals logo
Country United States
Founded 1983
Industry Biotechnology
Sector Healthcare
Employees 155
CEO Jyotindra Gange

Contact Details

Address:
5360 Northwest 35th Avenue
Fort Lauderdale, Florida 33309
United States
Phone 954-486-4590

Stock Details

Ticker Symbol SYVC
Exchange OTCMKTS
Stock Type Common Stock
Fiscal Year November - October
Reporting Currency USD
ISIN Number US87163M1018
SIC Code 2834

Key Executives

Name Position
John R. Palmer Chairman of InCon Technologies Inc.& Incon International Ltd. and Chief Executive Officer of InCon Technologies Inc
Jyotindra R. Gange Interim Principal Executive Officer and Director